MedBioSphere
Articles Videos The Web  
    

Ocera Therapeutics Receives Orphan

Selected Abstract

Ocera Therapeutics Receives Orphan Drug Status for AST-120 for Pouchitis.
Company to Present at 26th Annual JP Morgan Healthcare Conference SAN DIEGO, Jan. 7 /PRNewswire/ -- Ocera Therapeutics, Inc., a privately-held biopharmaceutical company focused on the development and commercialization of proprietary compounds to treat gastrointestinal and liver diseases, announced ...
January 7, 2008; PR Newswire

Read the full article with a free-trial membership at HighBeam Research



Related Articles

1. Ocera Therapeutics Receives Orphan Drug Status for AST-120 for Pouchitis.